GRDN
Guardian Pharmacy
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About GRDN
Guardian Pharmacy Services, Inc.
A leading and highly differentiated long-term care pharmacy services provider
Healthcare Providers and Services
11/16/2021
09/26/2024
New York Stock Exchange
3,400
12-31
Common stock
300 Galleria Parkway SE, Suite 800, Atlanta, Georgia 30339
--
Guardian Pharmacy Services, Inc., was incorporated in Delaware on November 16, 2021. The company is a leading, highly differentiated pharmacy services company that provides a wide range of technical support services designed to help LTCF patients adhere to their appropriate medication regimens, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, dispensing and dosing capabilities that are tailored to meet the needs of historically low-vision LTCF (such as ALF and BHF) patients.
Company Financials
EPS
GRDN has released its 2025 Q1 earnings. EPS was reported at 0.15, versus the expected 0.22, missing expectations. The chart below visualizes how GRDN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
GRDN has released its 2025 Q1 earnings report, with revenue of 329.31M, reflecting a YoY change of 19.57%, and net profit of 9.27M, showing a YoY change of 30.70%. The Sankey diagram below clearly presents GRDN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
